Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

NJEDA: International Company Crystal Pharmatech Finds CCIT an Optimal Spot for First US Location

8/5/2016

0 Comments

 
Trenton, NJ ― In addition to the dozens of New Jersey entrepreneurs who have used the New Jersey Economic Development Authority’s (EDA) Commercialization Center for Innovative Technologies (CCIT) over the last decade and a half as a springboard to grow their companies, several international companies have found the life sciences incubator an ideal location to establish their United States presence.
 
Of the nearly two-dozen current CCIT tenants, four, including China-based Crystal Pharmatech, are US entities of larger international companies. The additional international companies include FLUIDDA from Belgium, Shionogi from Japan, and Aucta Pharmaceuticals from China.
 
“The types of resources that make New Jersey and CCIT perfect for the State’s emerging biotechnology companies are the same assets that attract international companies to the Garden State and our life sciences incubator,” EDA Chief Executive Officer Melissa Orsen said.
 
CCIT offers tenant companies affordable lab and office space, assistance with identifying funding sources, including state incentives, help making matches to private sector support, and access to small business development resources and administrative support. 
​CCIT entrepreneurs also have access to educational and support programs such as a Lunch and Learn series, during which local entrepreneurs speak about best practices in their areas of expertise.
 
Crystal Pharmatech, a contract research organization (CRO) that aims to help clients reduce research and development costs and deliver medicine to treat unmet needs, opened its doors at CCIT in March 2014.
 
The CRO, which currently has seven employees at CCIT, has benefited immensely from establishing itself in New Jersey, and specifically at CCIT.
 
“Over the last two and a half years, we have grown tremendously thanks, in large part, to the resources provided by CCIT,” Crystal Pharmatech Vice President of Business Development Robert Wenslow said.  “From the walk-in ready lab space to the excellent and accessible staff, CCIT has met all of our needs as we’ve grown.”
 
Wenslow also noted that the state’s proximity to pharmaceutical giants played a factor in the company’s decision to locate in New Jersey. Fourteen of the world’s leading biopharmaceutical companies have locations in the Garden State.
 
During its time at CCIT, Crystal Pharmatech has grown its client base to include more than 150 global pharmaceutical companies.  The company partners with these clients to ensure comprehensive solutions for their needs in solid-state research, crystallization process development and pre-formulation studies.
 
It also guides them through the optimal solid phase for drug development, using all aspects of pre-formulation studies, including regulatory support and intellectual property protection.
 
Wenslow is familiar with New Jersey’s biopharmaceutical community, having worked at Merck in Rahway prior to joining Crystal Pharmatech. Several other individuals on the CRO’s executive team have strong ties to New Jersey and its pharmaceutical ecosystem; its co-founders CEO Alex Chen and Chief Scientific Officer Yanfeng Zhang received their education at Rutgers and Princeton Universities respectively and worked at Merck in Rahway prior to starting Crystal Pharmatech. Ann Newman, the company’s vice president of scientific development, worked for Bristol-Myers Squibb in Princeton before arriving at Crystal Pharmatech.
 
@NJEDATech spoke with Wenslow about Crystal Pharmatech’s experience at CCIT and its plans for the future:
 
Why did you choose to grow your company in New Jersey?
 
We found New Jersey to be a central hub for both our clients and New Jersey’s talented employee-pool. Locating in an area so densely populated with pharmaceutical companies has been beneficial to our company.
 
What do you consider Crystal Pharmatech’s biggest success to date?
 
We would consider our New Jersey expansion efforts our biggest success to date!  We started out being a “China lab” company.  We had doubts that our competitive advantage would lead to a successful lab in the US.  But in our business, it’s all about the science. Hire good people, perform good science, and the business will come!
 
What’s on the horizon for Crystal Pharmatech?
 
We are looking to expand lab space and capabilities. We are realizing that focused early formulation development research is lacking in the CRO world. We’re going to try and fill that gap.
 
What advice would you give to entrepreneurs just starting out?
 
Know your client base well and your competition better. Find your competitive advantage and focus like a laser beam.
 
For more information about resources available to support New Jersey’s technology industry, visit http://www.njeda.com/tls.
 
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
222 West State Street
Suite 302
Trenton, NJ 08608
732-729-9619